{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:06:00Z","timestamp":1767859560429,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Korea University grant","award":["K2011221"],"award-info":[{"award-number":["K2011221"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00417-020-05051-6","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T16:06:47Z","timestamp":1610122007000},"page":"1711-1721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Choroidal thickness profile and clinical outcomes in eyes with polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"259","author":[{"given":"Young Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-6562","authenticated-orcid":false,"given":"Jaeryung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"5051_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","volume":"15","author":"RF Spaide","year":"1995","unstructured":"Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15:100\u2013110. https:\/\/doi.org\/10.1097\/00006982-199515020-00003","journal-title":"Retina"},{"key":"5051_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1\u20138","journal-title":"Retina"},{"key":"5051_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53:107\u2013139. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.002","journal-title":"Prog Retin Eye Res"},{"key":"5051_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/iae.0000000000002019","volume":"39","author":"J Lee","year":"2019","unstructured":"Lee J, Byeon SH (2019) Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study. Retina 39:670\u2013678. https:\/\/doi.org\/10.1097\/iae.0000000000002019","journal-title":"Retina"},{"key":"5051_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajo.2015.12.024","volume":"164","author":"DS Ting","year":"2016","unstructured":"Ting DS, Ng WY, Ng SR, Tan SP, Yeo IY, Mathur R, Chan CM, Tan AC, Tan GS, Wong TY, Cheung CM (2016) Choroidal thickness changes in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study. Am J Ophthalmol 164:128\u2013136.e121. https:\/\/doi.org\/10.1016\/j.ajo.2015.12.024","journal-title":"Am J Ophthalmol"},{"key":"5051_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","volume":"118","author":"SE Chung","year":"2011","unstructured":"Chung SE, Kang SW, Lee JH, Kim YT (2011) Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118:840\u2013845. https:\/\/doi.org\/10.1016\/j.ophtha.2010.09.012","journal-title":"Ophthalmology"},{"key":"5051_CR7","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/iae.0000000000001481","volume":"37","author":"P Gupta","year":"2017","unstructured":"Gupta P, Ting DSW, Thakku SG, Wong TY, Cheng CY, Wong E, Mathur R, Wong D, Yeo I, Gemmy Cheung CM (2017) Detailed characterization of choroidal morphologic and vascular features in age-related macular degeneration and polypoidal choroidal vasculopathy. Retina 37:2269\u20132280. https:\/\/doi.org\/10.1097\/iae.0000000000001481","journal-title":"Retina"},{"key":"5051_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/iae.0000000000002583","volume":"40","author":"YC Chang","year":"2020","unstructured":"Chang YC, Cheng CK (2020) Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina. 40:1403\u20131411. https:\/\/doi.org\/10.1097\/iae.0000000000002583","journal-title":"Retina."},{"key":"5051_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1167\/iovs.03-0469","volume":"45","author":"SS Hayreh","year":"2004","unstructured":"Hayreh SS (2004) Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture. Invest Ophthalmol Vis Sci 45:749\u2013757; 748. https:\/\/doi.org\/10.1167\/iovs.03-0469","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5051_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00417-015-3054-7","volume":"254","author":"C Yun","year":"2016","unstructured":"Yun C, Oh J, Ahn SE, Hwang SY, Kim SW, Huh K (2016) Peripapillary choroidal thickness in patients with early age-related macular degeneration and reticular pseudodrusen. Graefes Arch Clin Exp Ophthalmol 254:427\u2013435. https:\/\/doi.org\/10.1007\/s00417-015-3054-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5051_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230293","volume":"15","author":"HM Kang","year":"2020","unstructured":"Kang HM, Kim EW, Choi JH, Koh HJ, Lee SC (2020) Focal lamina cribrosa defects and significant peripapillary choroidal thinning in patients with unilateral branch retinal vein occlusion. PLoS One 15:e0230293. https:\/\/doi.org\/10.1371\/journal.pone.0230293","journal-title":"PLoS One"},{"key":"5051_CR12","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/iae.0000000000000539","volume":"35","author":"C Yun","year":"2015","unstructured":"Yun C, Oh J, Han JY, Hwang SY, Moon SW, Huh K (2015) Peripapillary choroidal thickness in central serous chorioretinopathy: is choroid outside the macula also thick? Retina 35:1860\u20131866. https:\/\/doi.org\/10.1097\/iae.0000000000000539","journal-title":"Retina"},{"key":"5051_CR13","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1097\/iae.0000000000002758","volume":"40","author":"KT Nam","year":"2020","unstructured":"Nam KT, Chung HW, Jang S, Kim SW, Oh J, Yun C (2020) Features of the macular and peripapillary choroid and choriocapillaris in eyes with nonexudative age-related macular degeneration. Retina 40:2270\u20132276. https:\/\/doi.org\/10.1097\/iae.0000000000002758","journal-title":"Retina"},{"key":"5051_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3341\/kjo.2016.0101","volume":"31","author":"KH Lee","year":"2017","unstructured":"Lee KH, Kim SH, Lee JM, Kang EC, Koh HJ (2017) Peripapillary choroidal thickness change of polypoidal choroidal vasculopathy after anti-vascular endothelial growth factor. Korean J Ophthalmol 31:431\u2013438. https:\/\/doi.org\/10.3341\/kjo.2016.0101","journal-title":"Korean J Ophthalmol"},{"key":"5051_CR15","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00417-019-04432-w","volume":"257","author":"B Lee","year":"2019","unstructured":"Lee B, Yoo G, Yun C, Oh J (2019) Short-term effects of anti-vascular endothelial growth factor on peripapillary choroid and choriocapillaris in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 257:2163\u20132172. https:\/\/doi.org\/10.1007\/s00417-019-04432-w","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5051_CR16","doi-asserted-by":"publisher","first-page":"16204","DOI":"10.1038\/srep16204","volume":"5","author":"M Miyake","year":"2015","unstructured":"Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, Ueda-Arakawa N, Oishi A, Nakanishi H, Tamura H, Tsujikawa A, Yoshimura N (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204. https:\/\/doi.org\/10.1038\/srep16204","journal-title":"Sci Rep"},{"key":"5051_CR17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00417-015-3221-x","volume":"254","author":"H Kim","year":"2016","unstructured":"Kim H, Lee SC, Kwon KY, Lee JH, Koh HJ, Byeon SH, Kim SS, Kim M, Lee CS (2016) Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254:1497\u20131503. https:\/\/doi.org\/10.1007\/s00417-015-3221-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5051_CR18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1136\/bjophthalmol-2015-308074","volume":"100","author":"JH Kim","year":"2016","unstructured":"Kim JH, Lee TG, Chang YS, Kim CG, Cho SW (2016) Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. Br J Ophthalmol 100:1634\u20131639. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-308074","journal-title":"Br J Ophthalmol"},{"key":"5051_CR19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/bjophthalmol-2014-306432","volume":"99","author":"H Koizumi","year":"2015","unstructured":"Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2015) Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study. Br J Ophthalmol 99:1284\u20131288. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306432","journal-title":"Br J Ophthalmol"},{"key":"5051_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajo.2014.12.025","volume":"159","author":"H Koizumi","year":"2015","unstructured":"Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Kawasaki R, Sekiryu T, Okada AA, Iida T (2015) Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration. Am J Ophthalmol 159:627\u2013633. https:\/\/doi.org\/10.1016\/j.ajo.2014.12.025","journal-title":"Am J Ophthalmol"},{"key":"5051_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ophtha.2015.10.039","volume":"123","author":"H Koizumi","year":"2016","unstructured":"Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2016) Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results. Ophthalmology 123:617\u2013624. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.039","journal-title":"Ophthalmology"},{"key":"5051_CR22","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.1038\/s41598-019-47738-9","volume":"9","author":"N Nagai","year":"2019","unstructured":"Nagai N, Suzuki M, Minami S, Kurihara T, Kamoshita M, Sonobe H, Watanabe K, Uchida A, Shinoda H, Tsubota K, Ozawa Y (2019) Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. Sci Rep 9:11389. https:\/\/doi.org\/10.1038\/s41598-019-47738-9","journal-title":"Sci Rep"},{"key":"5051_CR23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1167\/iovs.17-22144","volume":"59","author":"N Padron-Perez","year":"2018","unstructured":"Padron-Perez N, Arias L, Rubio M, Lorenzo D, Garcia-Bru P, Catala-Mora J, Caminal JM (2018) Changes in choroidal thickness after intravitreal injection of anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Invest Ophthalmol Vis Sci 59:1119\u20131124. https:\/\/doi.org\/10.1167\/iovs.17-22144","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5051_CR24","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1097\/iae.0000000000002259","volume":"39","author":"JW Jang","year":"2019","unstructured":"Jang JW, Kim JM, Kang SW, Kim SJ, Bae K, Kim KT (2019) Typical polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 39:1995\u20132003. https:\/\/doi.org\/10.1097\/iae.0000000000002259","journal-title":"Retina"},{"key":"5051_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/aos.12653","volume":"93","author":"JY Shin","year":"2015","unstructured":"Shin JY, Kwon KY, Byeon SH (2015) Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Acta Ophthalmol 93:524\u2013532. https:\/\/doi.org\/10.1111\/aos.12653","journal-title":"Acta Ophthalmol"},{"key":"5051_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1167\/iovs.11-8782","volume":"53","author":"CS Tan","year":"2012","unstructured":"Tan CS, Ouyang Y, Ruiz H, Sadda SR (2012) Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:261\u2013266. https:\/\/doi.org\/10.1167\/iovs.11-8782","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5051_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bjophthalmol-2012-302393","volume":"97","author":"S Sizmaz","year":"2013","unstructured":"Sizmaz S, Kucukerdonmez C, Pinarci EY, Karalezli A, Canan H, Yilmaz G (2013) The effect of smoking on choroidal thickness measured by optical coherence tomography. Br J Ophthalmol 97:601\u2013604. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302393","journal-title":"Br J Ophthalmol"},{"key":"5051_CR28","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1167\/iovs.18-25018","volume":"59","author":"M Lee","year":"2018","unstructured":"Lee M, Lee H, Kim HC, Chung H (2018) Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases. Invest Ophthalmol Vis Sci 59:4896\u20134908. https:\/\/doi.org\/10.1167\/iovs.18-25018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5051_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ajo.2010.10.030","volume":"151","author":"I Maruko","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T (2011) Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 151:594\u2013603.e591. https:\/\/doi.org\/10.1016\/j.ajo.2010.10.030","journal-title":"Am J Ophthalmol"},{"key":"5051_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ajo.2013.07.001","volume":"156","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Kim HS, Jang YS, Han JI, Lew YJ, Lee TG, Kim CG, Kim JW (2013) Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. Am J Ophthalmol 156:1192\u20131200.e1191. https:\/\/doi.org\/10.1016\/j.ajo.2013.07.001","journal-title":"Am J Ophthalmol"},{"key":"5051_CR31","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1167\/iovs.12-9619","volume":"53","author":"P Jirarattanasopa","year":"2012","unstructured":"Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N (2012) Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 53:3663\u20133672. https:\/\/doi.org\/10.1167\/iovs.12-9619","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-05051-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T03:53:18Z","timestamp":1626234798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-05051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5051"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-05051-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approved by the Institutional Review Board of the Korea University Hospital, Seoul, Korea (IRB number: 2020AN0159), and adhered to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This retrospective study involves no more than minimal risk to subjects, and the IRB of the Korea University Hospital approved our request to waive the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}